Skip to main content
. 2015 Jul 12;2015:175436. doi: 10.1155/2015/175436

Table 2.

Gastrointestinal symptoms at baseline and after 1 year according to randomization group.

Gastrointestinal symptom rating scale, median (IQR) Baseline 1 year p value
Placebo PPI Placebo PPI
N = 85 N = 86 N = 69 N = 79
Total score 2.6 (2.4; 2.8) 2.5 (2.3; 2.7) 1.9 (1.7; 2.1) 1.8 (1.7; 2.0) 0.73
Abdominal pain 2.7 (2.4; 3.0) 2.6 (2.4; 2.8) 2.0 (1.8; 2.3) 1.8 (1.6; 2.0) 0.58
Reflux 3.2 (2.8; 3.5) 3.1 (2.7; 3.4) 1.8 (1.6; 2.0) 1.8 (1.6; 2.0) 0.74
Indigestion 3.1 (2.8; 3.3) 3.0 (2.7; 3.2) 2.2 (2.0; 2.5) 2.2 (1.9; 2.4) 0.83
Diarrhea 2.2 (1.9; 2.5) 1.9 (1.6; 2.1) 1.6 (1.4; 1.8) 1.5 (1.3; 1.7) 0.48
Constipation 2.2 (1.9; 2.5) 2.0 (1.7; 2.3) 1.8 (1.5; 2.0) 1.7 (1.5; 2.0) 0.88

Esomeprazole 40 mg.

Gastrointestinal symptom rating scale. Range 1–7. Increasing values reflect increasing symptoms.

Between group comparison. Difference in GSRS score at entry versus one year. Conditional linear regression adjusted for GP clusters.